Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

NOD-scid IL2rgamma(null) mouse model of human skin transplantation and allograft rejection.

Racki WJ, Covassin L, Brehm M, Pino S, Ignotz R, Dunn R, Laning J, Graves SK, Rossini AA, Shultz LD, Greiner DL.

Transplantation. 2010 Mar 15;89(5):527-36. doi: 10.1097/TP.0b013e3181c90242.

2.

Alloimmune injury and rejection of human skin grafts on human peripheral blood lymphocyte-reconstituted non-obese diabetic severe combined immunodeficient beta2-microglobulin-null mice.

Turgeon NA, Banuelos SJ, Shultz LD, Lyons BL, Iwakoshi N, Greiner DL, Mordes JP, Rossini AA, Appel MC.

Exp Biol Med (Maywood). 2003 Oct;228(9):1096-104.

PMID:
14530522
3.

Development of novel major histocompatibility complex class I and class II-deficient NOD-SCID IL2R gamma chain knockout mice for modeling human xenogeneic graft-versus-host disease.

Pino S, Brehm MA, Covassin-Barberis L, King M, Gott B, Chase TH, Wagner J, Burzenski L, Foreman O, Greiner DL, Shultz LD.

Methods Mol Biol. 2010;602:105-17. doi: 10.1007/978-1-60761-058-8_7.

6.

Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice.

Ishikawa F, Yasukawa M, Lyons B, Yoshida S, Miyamoto T, Yoshimoto G, Watanabe T, Akashi K, Shultz LD, Harada M.

Blood. 2005 Sep 1;106(5):1565-73. Epub 2005 May 26.

7.

Human peripheral blood CD4 T cell-engrafted non-obese diabetic-scid IL2rγ(null) H2-Ab1 (tm1Gru) Tg (human leucocyte antigen D-related 4) mice: a mouse model of human allogeneic graft-versus-host disease.

Covassin L, Laning J, Abdi R, Langevin DL, Phillips NE, Shultz LD, Brehm MA.

Clin Exp Immunol. 2011 Nov;166(2):269-80. doi: 10.1111/j.1365-2249.2011.04462.x.

8.

Development of a humanized mouse model to study the role of macrophages in allograft injury.

Kirkiles-Smith NC, Harding MJ, Shepherd BR, Fader SA, Yi T, Wang Y, McNiff JM, Snyder EL, Lorber MI, Tellides G, Pober JS.

Transplantation. 2009 Jan 27;87(2):189-97. doi: 10.1097/TP.0b013e318192e05d.

9.

A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene.

King M, Pearson T, Shultz LD, Leif J, Bottino R, Trucco M, Atkinson MA, Wasserfall C, Herold KC, Woodland RT, Schmidt MR, Woda BA, Thompson MJ, Rossini AA, Greiner DL.

Clin Immunol. 2008 Mar;126(3):303-14. Epub 2007 Dec 21.

PMID:
18096436
10.

Chronic human skin graft rejection in severe combined immunodeficient mice engrafted with human PBL from an HLA-presensitized donor.

Kawamura T, Niguma T, Fechner JH Jr, Wolber R, Beeskau MA, Hullett DA, Sollinger HW, Burlingham WJ.

Transplantation. 1992 Mar;53(3):659-65.

PMID:
1549862
11.

NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells.

Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, Hioki K, Ueyama Y, Koyanagi Y, Sugamura K, Tsuji K, Heike T, Nakahata T.

Blood. 2002 Nov 1;100(9):3175-82.

12.

Non-obese diabetic-recombination activating gene-1 (NOD-Rag1 null) interleukin (IL)-2 receptor common gamma chain (IL2r gamma null) null mice: a radioresistant model for human lymphohaematopoietic engraftment.

Pearson T, Shultz LD, Miller D, King M, Laning J, Fodor W, Cuthbert A, Burzenski L, Gott B, Lyons B, Foreman O, Rossini AA, Greiner DL.

Clin Exp Immunol. 2008 Nov;154(2):270-84. doi: 10.1111/j.1365-2249.2008.03753.x. Epub 2008 Sep 8.

13.

Immunodeficient mouse strains display marked variability in growth of human melanoma lung metastases.

Carreno BM, Garbow JR, Kolar GR, Jackson EN, Engelbach JA, Becker-Hapak M, Carayannopoulos LN, Piwnica-Worms D, Linette GP.

Clin Cancer Res. 2009 May 15;15(10):3277-86. doi: 10.1158/1078-0432.CCR-08-2502. Epub 2009 May 15.

14.

Human nasal polyp microenvironments maintained in a viable and functional state as xenografts in NOD-scid IL2rgamma(null) mice.

Bernstein JM, Brooks SP, Lehman HK, Pope L, Sands A, Shultz LD, Bankert RB.

Ann Otol Rhinol Laryngol. 2009 Dec;118(12):866-75.

15.

Comparison of human cord blood engraftment between immunocompromised mouse strains.

McDermott SP, Eppert K, Lechman ER, Doedens M, Dick JE.

Blood. 2010 Jul 15;116(2):193-200. doi: 10.1182/blood-2010-02-271841. Epub 2010 Apr 19.

16.

Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells.

Shultz LD, Lyons BL, Burzenski LM, Gott B, Chen X, Chaleff S, Kotb M, Gillies SD, King M, Mangada J, Greiner DL, Handgretinger R.

J Immunol. 2005 May 15;174(10):6477-89.

17.

The allogeneic response to cultured human skin equivalent in the hu-PBL-SCID mouse model of skin rejection.

Briscoe DM, Dharnidharka VR, Isaacs C, Downing G, Prosky S, Shaw P, Parenteau NL, Hardin-Young J.

Transplantation. 1999 Jun 27;67(12):1590-9.

PMID:
10401767
19.

Allogeneic versus xenogeneic immune reaction to bioengineered skin grafts.

Erdag G, Morgan JR.

Cell Transplant. 2004;13(6):701-12.

PMID:
15648740
20.

Skin allografts--lymph veiled (dendritic) cells are responsible for initiation of rejection in canine skin/SCID mouse chimera model.

Galkowska H, Olszewski WL, Moscicka M, Cybulska E, Ziolkowska A, Wojewodzka U, Mijal J.

Ann Transplant. 1999;4(3-4):5-10.

PMID:
10853773

Supplemental Content

Support Center